Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is managed by a team of experienced professionals and invests on behalf of a number of blue chip institutional investors. Kester Capital is currently investing its second fund, which was raised in 2013. Kester Capital's target equity investment size is £5 – 25 million.
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. The company’s lead product, StarDrop, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston, US. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. The company’s lead product, StarDrop, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston, US. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.
We exist because regulation is complex. VIXIO provides the independent path to truth. VIXIO is the most trusted source for independent, authoritative and actionable intelligence on fast-moving regulatory developments. We help businesses globally in making timely, informed decisions to mitigate regulatory risk and capitalise on new opportunities, within the payments and gambling industries.
ComplianceOnline is the provider of legal, regulatory and business intelligence for the gambling and payments industries. We specialise in providing high level and independent insights, analysis, data and research through our primary services GamblingCompliance and PaymentsCompliance. Through our advanced web-based technology platform we provide industry professionals with the critical information they need to understand what regulatory change today means for the business opportunities of tomorrow. We pride ourselves on providing the most comprehensive, accurate and up-to-date information services and eLearning courses. Based in London, Washington, D.C., California and Taipei, ComplianceOnlines’s team of in-house analysts and journalists boast an unrivaled network of contacts among policymakers, lobbyists and legal experts, as well as a wealth of experience to analyse what regulatory change and market developments today, means for business opportunities tomorrow. Our clients include global law firms and legal professionals, regulators, advisory communities, online and terrestrial operators, lotteries, financial institutions, fintech and start-up companies, and payment technology and service providers. Learn more at: https://gamblingcompliance.com/ https://paymentscompliance.com/
CETA Insurance is an innovator in personal and commercial insurance distribution. Since inception, CETA has been at the forefront of tech-enabled insurance distribution and niche product and channel development. CETA has been successful at leveraging its online broking platform, diverse range of insurer relationships, strong digital marketing skills and deep data insights to develop market leading positions and recurring customer relationships in its core markets and channels.
Avania is a full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics, and device-drug combination products internationally.
Frontier Medical Group is one of the leading suppliers of consumable products and services to healthcare providers in the UK, Europe and International.
Garrets International provides outsourced marine catering management for the commercial shipping industry. Garrets manages approximately 1000 vessels on behalf of some of the largest names in world shipping.
AgriBriefing is a business media company that specializes in pricing, data, marketing solutions, news, market intelligence, and insight. The business began with the launch of TheMediaBriefing - which provides strategic insight and market intelligence for senior decision makers in the global media industry - but expanded significantly in 2012 with the private equity-backed acquisition of Farmers Guardian and Pulse from UBM. Further acquisitions of LAMMA (the U.K.'s leading agricultural equipment and services exhibition) and Agrimoney (an award-winning intelligence portal covering the world of international agribusiness) followed alongside the sale of the Pulse healthcare business to Cogora Ltd. In July 2015 Briefing Media entered into a new financing agreement with Lyceum Capital Partners to support our continued growth. The company currently operates in the media strategy and agriculture industries (where we reach around 250,000 farming decision makers across our expanding range of products and services). AgriBriefing was founded in 2010 by seasoned media executives Neil Thackray & Rory Brown and is headquartered in London, UK.
Chiltern International Limited, a contract research organization, provides clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies.
Chiltern International Limited, a contract research organization, provides clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies.
Travel Entertainment Group, Ltd.
Private Equity Round in 2008
Travel Entertainment Group, Ltd. provides entertainment services to the airline industry.
Ironshore provides broker-sourced specialty property and casualty insurance coverages for varying risks located throughout the world. Select specialty coverages are underwritten at Lloyd’s through Ironshore’s Pembroke Syndicate 4000. The Ironshore group of companies is rated A (Excellent) by A.M Best with a Financial Size Category of Class XIV. Pembroke Syndicate 4000 operates within Lloyd’s where the market rating is A (Excellent) by A.M. Best, AA- (Very Strong) by Fitch, and A+ (Strong) by Standard & Poor’s.
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.